+972.9.767.7039 (Israel)
Supporting Literature
The Impact of Monitored Home-Based Exercise Using Wearable Technology Compared to a Standard Cardiac Rehabilitation Program in Patients with Ischemic Heart Disease*.
HealthWatch is pleased to announce the incredible results of the first patients of the HealthWatch – O2 Rehabilitation Center clinical trial. Additional details will be published at the end of the trial.
Read MoreEffects of Hypoglycemia on Cardiac Rhythm Homeostasis
The Dead-in-Bed Syndrome – Effects of Hypoglycemia on Cardiac Rhythm Homeostasis, Prof. Wijns, The Lambe Institute for Translational Medicine & Curam, Saolta Healthcare Group, National University of Ireland, Galway.
International Conference for Innovations (ICI) in Cardiovascular Systems, December 3-5, 2017, Tel-Aviv, Israel
Read MoreProspective validation of a novel wearable full 12-lead cardiac telemetry system to provide adequate detection and interpretation of ischemic STT changes and dysrhythmic events
Jacob Erel MD, Hila Dagan PhD and Morris Mosseri MD
October 2017
Ischemic or dysrhythmic episodes during continuous ECG recording are related to worse outcome. Yet, off-line Holter or even on-line ICU telemetric monitoring detection, is limited to 3-leads, whereas full 12-lead ECG is superior.
Wearable Tech: Leveraging Canadian Innovation to Improve Health
Salah, H. et al.
March 2014
Secondary research reveals that wearables have been around for years. They hold tremendous potential to impact user’s lives in terms of their health, how they interact and communicate, and how they accomplish tasks and track data. The wearables market is expected to reach billions of dollars. Wearables are small electronic devices, often consisting of one or more sensors and having computational capability. They are embedded into items that attach to the body, such as a user’s head, feet, arms, wrists and waist. They can resemble a watch, eyeglasses, clothing, contact lenses, shoes or even jewelry. Wearables either capture data or present data.
Technology Review of Remote Patient Monitoring Devices
Author: Health Enterprise East
The different devices reviewed in this report indicate a growing trend in providing portable and wearable products for patients, to improving ease of use and patience compliance. Such product releases are being supported by intensive research and development in RF communication strategies, device miniaturization and battery technologies.
Significance of Continuous 12/15-Lead ECG Monitoring in CHD/ACS Patients
Dr. Jacob Erel, Director of Nuclear Cardiology Uni & Coronary CT Service, Meir Medical Center, Israel
October 2016
12-lead recording is needed for accurate programming of catheter ablation, for patients with supraventricular tachycardia. Same is for patients with premature beats, who may develop reduced heart function, where treatment may be even lifesaving.
